Alsin, ABclonal, A7125

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human Amyotrophic lateral sclerosis 2 protein and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 4 commercial research antibodies against human Amyotrophic lateral sclerosis 2 protein necoded by ALS2

The collection of antibodies was tested using HAP1 WT and ALS2 KO cells in WB (WT and KO cell lysates/30 µg protein) according to YCharOS standard protocols (see reference).

In WB (1:500 ab dilution) A7125 detected a faint band of appr. 183 kDa in WT cell lysate with no corresponding band observed in KO cell lysate.